Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell, Cutaneous

Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.

387 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Cutaneous trial results

Completed

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

NCT01273090

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +58 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Completed

Aminocamptothecin in Treating Patients With T-cell Lymphoma

NCT00002635

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • New England Medical Center Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

NCT00006340

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +47 more
Locations
  • Methodist Cancer Center at Methodist Hospital Indianapolis, Indiana, United States
  • Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Hopital Necker Paris, France
View Trial Details

Related conditions